{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:26:03Z","timestamp":1793949963088,"version":"4.8.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The role of type I IFNs (IFN-I) in the promotion of autoimmunity has been well established. However, its role in the skin fibrosis of systemic sclerosis (SSc) is less clear. IFN-I can participate to tissue repair, and, here, we will consider the extent to which IFN-I's role in SSc skin fibrosis may reflect in part IFN-I functions during wound healing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Studies are beginning to delineate whether IFN-I has a protective or pathogenic role and how IFN-I affects tissue biology. Recent support for a pathogenic role came from a study depleting plasmacytoid dendritic cells during bleomycin-induced skin fibrosis. The depletion reduced the bleomycin-induced IFN-I-stimulated transcripts and both prevented and reversed fibrosis. Additionally, two recent articles, one identifying SSc endothelial cell injury markers and one showing repressed IFN signaling in SSc keratinocytes, suggest the possibility of unbalanced IFN-I activities on distinct cells types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Recent results support a pathogenic role for IFN-I in skin fibrosis, and recent studies along with others suggest a scenario whereby SSc skin damage results from too much IFN-I-activity driving vasculopathy in combination with too little IFN-I-mediated epidermal integrity and antifibrotic fibroblast phenotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000659","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:13:09Z","timestamp":1566418389000},"page":"569-575","source":"Crossref","is-referenced-by-count":20,"title":["Role of type I interferons and innate immunity in systemic sclerosis: unbalanced activities on distinct cell types?"],"prefix":"10.1097","volume":"31","author":[{"given":"Franck J.","family":"Barrat","sequence":"first","affiliation":[{"name":"Autoimmunity and Inflammation Program, HSS Research Institute"},{"name":"David Z. Rosensweig Genomics Research Center"},{"name":"Department of Microbiology and Immunology, Weill Cornell Medical College of Cornell University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa T.","family":"Lu","sequence":"additional","affiliation":[{"name":"Autoimmunity and Inflammation Program, HSS Research Institute"},{"name":"Division of Pediatric Rheumatology, Department of Medicine, Hospital for Special Surgery"},{"name":"Department of Microbiology and Immunology, Weill Cornell Medical College of Cornell University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev-virology-100114-055249","article-title":"No love lost between viruses and interferons","volume":"2","author":"Fensterl","year":"2015","journal-title":"Annu Rev Virol"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","article-title":"Type I interferons in autoimmune disease","volume":"14","author":"Crow","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-med-052814-023338","article-title":"Importance of nucleic acid recognition in inflammation and autoimmunity","volume":"67","author":"Barrat","year":"2016","journal-title":"Annu Rev Med"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Ah Kioon","year":"2018","journal-title":"Sci Transl Med"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J Exp Med"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.20051696","article-title":"Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8","volume":"202","author":"Vollmer","year":"2005","journal-title":"J Exp Med"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J Clin Invest"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature09102","article-title":"TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus","volume":"465","author":"Guiducci","year":"2010","journal-title":"Nature"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2013.00266","article-title":"The role of type 1 interferon in systemic sclerosis","volume":"4","author":"Wu","year":"2013","journal-title":"Front Immunol"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fimmu.2018.01702","article-title":"Innate immunity in systemic sclerosis fibrosis: recent advances","volume":"9","author":"Laurent","year":"2018","journal-title":"Front Immunol"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM197907053010102","article-title":"Immune interferon in the circulation of patients with autoimmune disease","volume":"301","author":"Hooks","year":"1979","journal-title":"N Engl J Med"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/art.1780250407","article-title":"Serum interferon levels in patients with systemic lupus erythematosus","volume":"25","author":"Ytterberg","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero","year":"2017","journal-title":"Nat Commun"},{"key":"R19-20230828","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J Exp Med"},{"key":"R20-20230828","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1084\/jem.20132522","article-title":"Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"211","author":"Sisirak","year":"2014","journal-title":"J Exp Med"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus","volume":"129","author":"Furie","year":"2019","journal-title":"J Clin Invest"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/jid.2008.96","article-title":"An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in \u2018interface dermatitis\u2019","volume":"128","author":"Wenzel","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20101102","article-title":"Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons","volume":"207","author":"Gregorio","year":"2010","journal-title":"J Exp Med"},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.chom.2014.11.004","article-title":"Type I interferons link viral infection to enhanced epithelial turnover and repair","volume":"17","author":"Sun","year":"2015","journal-title":"Cell Host Microbe"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1084\/jem.20101048","article-title":"Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9","volume":"207","author":"Guiducci","year":"2010","journal-title":"J Exp Med"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.4049\/jimmunol.1003007","article-title":"Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice","volume":"186","author":"Lin","year":"2011","journal-title":"J Immunol"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"eaag2513","DOI":"10.1126\/scitranslmed.aag2513","article-title":"RIG-I\/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury","volume":"9","author":"Fischer","year":"2017","journal-title":"Sci Transl Med"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.39987","article-title":"Ultraviolet B irradiation causes stimulator of interferon genes\u2013dependent production of protective type I interferon in mouse skin by recruited inflammatory monocytes","volume":"69","author":"Sontheimer","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","article-title":"Antimicrobial peptide LL37 and MAVS signaling drive interferon-\u03b2 production by epidermal keratinocytes during skin injury","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"R32-20230828","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125067","article-title":"Macrophage IFN-I signaling promotes autoreactive T cell infiltration into islets in type 1 diabetes model","volume":"4","author":"Marro","year":"2019","journal-title":"JCI Insight"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"E3206","DOI":"10.1073\/pnas.1407068111","article-title":"Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages","volume":"111","author":"McComb","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fimmu.2018.00585","article-title":"Regulatory T-cells: potential regulator of tissue repair and regeneration","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.4049\/jimmunol.1500036","article-title":"IFN-alpha\/beta receptor signaling promotes regulatory T cell development and function under stress conditions","volume":"194","author":"Metidji","year":"2015","journal-title":"J Immunol"},{"key":"R36-20230828","first-page":"79","article-title":"Inhibition of wound healing in mice by local interferon alpha\/beta injection","volume":"74","author":"Stout","year":"1993","journal-title":"Int J Exp Pathol"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4049\/jimmunol.172.3.1699","article-title":"IFN-\u03b1 sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA","volume":"172","author":"Kaiser","year":"2004","journal-title":"J Immunol"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1128\/IAI.01564-13","article-title":"Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis","volume":"82","author":"Zhang","year":"2014","journal-title":"Infect Immun"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.celrep.2017.09.006","article-title":"Lymphatic vessels balance viral dissemination and immune activation following cutaneous viral infection","volume":"20","author":"Loo","year":"2017","journal-title":"Cell Rep"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","article-title":"The roles of type I interferon in bacterial infection","volume":"19","author":"Boxx","year":"2016","journal-title":"Cell Host Microbe"},{"key":"R41-20230828","article-title":"Type I interferon dysregulation in systemic sclerosis","author":"Skaug","year":"2019","journal-title":"Cytokine"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2017.10.011","article-title":"Targeting interferons as a strategy for systemic sclerosis treatment","volume":"195","author":"Ciechomska","year":"2018","journal-title":"Immunol Lett"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R44-20230828","doi-asserted-by":"crossref","first-page":"e0114017","DOI":"10.1371\/journal.pone.0114017","article-title":"Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts","volume":"10","author":"Johnson","year":"2015","journal-title":"PLoS One"},{"key":"R45-20230828","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R46-20230828","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.21894","article-title":"Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts","volume":"54","author":"Gardner","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R47-20230828","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/jid.2015.188","article-title":"Suppression of T cell activation and collagen accumulation by an anti-IFNAR1 mAb, anifrolumab, in adult patients with systemic sclerosis","volume":"135","author":"Guo","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R48-20230828","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.20160","article-title":"A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease","volume":"50","author":"Ruzek","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R49-20230828","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4049\/jimmunol.1502190","article-title":"Type I IFNs regulate inflammation, vasculopathy, and fibrosis in chronic cutaneous graft-versus-host disease","volume":"197","author":"Delaney","year":"2016","journal-title":"J Immunol"},{"key":"R50-20230828","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?","volume":"3","author":"Fleming","year":"2008","journal-title":"PLoS One"},{"key":"R51-20230828","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.3389\/fimmu.2018.02191","article-title":"Single cell RNA sequencing identifies HSPG2 and APLNR as markers of endothelial cell injury in systemic sclerosis skin","volume":"9","author":"Apostolidis","year":"2018","journal-title":"Front Immunol"},{"key":"R52-20230828","doi-asserted-by":"crossref","first-page":"e000286","DOI":"10.1136\/lupus-2018-000286","article-title":"Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE","volume":"5","author":"Casey","year":"2018","journal-title":"Lupus Sci Med"},{"key":"R53-20230828","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/rheumatology\/kex280","article-title":"Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta","volume":"56","author":"McCoy","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R54-20230828","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1465-9921-14-80","article-title":"Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease","volume":"14","author":"Lindahl","year":"2013","journal-title":"Respir Res"},{"key":"R55-20230828","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4049\/jimmunol.1801209","article-title":"Perivascular adventitial fibroblast specialization accompanies T cell retention in the inflamed human dermis","volume":"202","author":"Barron","year":"2019","journal-title":"J Immunol"},{"key":"R56-20230828","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1183\/09031936.00059507","article-title":"Interferon-\u03b2 augments eosinophil adhesion-inducing activity of endothelial cells","volume":"32","author":"Kobayashi","year":"2008","journal-title":"Eur Respir J"},{"key":"R57-20230828","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.ajpath.2016.06.020","article-title":"Altered dermal fibroblasts in systemic sclerosis display podoplanin and CD90","volume":"186","author":"Nazari","year":"2016","journal-title":"Am J Pathol"},{"key":"R58-20230828","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jid.2017.09.045","article-title":"SFRP2\/DPP4 and FMO1\/LSP1 define major fibroblast populations in human skin","volume":"138","author":"Tabib","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R59-20230828","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"R60-20230828","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"R61-20230828","doi-asserted-by":"crossref","first-page":"1014 e1016","DOI":"10.1016\/j.immuni.2018.04.006","article-title":"Single-cell RNA sequencing of lymph node stromal cells reveals niche-associated heterogeneity","volume":"48","author":"Rodda","year":"2018","journal-title":"Immunity"},{"key":"R62-20230828","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni.2262","article-title":"Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks","volume":"13","author":"Malhotra","year":"2012","journal-title":"Nat Immunol"},{"key":"R63-20230828","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.4049\/jimmunol.1300376","article-title":"A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling","volume":"191","author":"Fang","year":"2013","journal-title":"J Immunol"},{"key":"R64-20230828","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","article-title":"Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer","volume":"47","author":"Aden","year":"2008","journal-title":"Rheumatology (Oxford)"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T02:00:48Z","timestamp":1693188048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000659","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}